BFRI
Biofrontera Inc.NASDAQHealthcare$0.98+6.41%ClosedMarket Cap: $11.4M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.10
P/S
0.28
EV/EBITDA
-1.09
DCF Value
$-36.18
FCF Yield
-115.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
75.8%
Operating Margin
-27.2%
Net Margin
-25.3%
ROE
-1139.0%
ROA
-36.9%
ROIC
-66.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $17.1M | 84.0% | $4.6M | $5.6M | $0.48 | — |
| FY 2025 | $41.7M | 75.8% | $-11.3M | $-10.5M | $-0.90 | — |
| Q3 2025 | $7.0M | 72.5% | $-6.3M | $-6.6M | $-0.62 | — |
| Q2 2025 | $9.0M | 73.6% | $-5.1M | $-5.3M | $-0.57 | — |
| Q1 2025 | $8.6M | 64.2% | $-4.5M | $-4.2M | $-0.76 | — |
| Q4 2024 | $12.6M | 58.0% | $-1.7M | $-1.4M | $-0.19 | — |
| FY 2024 | $37.3M | 50.1% | $-17.2M | $-17.8M | $-3.22 | — |
| Q3 2024 | $9.0M | 45.9% | $-5.0M | $-5.7M | $-0.98 | — |
| Q2 2024 | $7.8M | 44.6% | $-5.1M | $-257.0K | $-0.05 | — |
| Q1 2024 | $7.9M | 50.1% | $-5.5M | $-10.4M | $-2.88 | — |
| Q4 2023 | $10.6M | 49.3% | $-3.9M | $3.5M | $1.65 | — |
| FY 2023 | $34.1M | 48.8% | $-22.7M | $-20.1M | $-13.02 | — |